Sangamo (SGMO) reported positive updated data from a Phase 1/2 study of its gene therapy candidate ST-920 in the treatment of Fabry disease. Read more here.

A Walker County mans has pleaded guilty in the death of his son. Jamie Rader was set to go on trial this week on murder ...

There’s a ways to go before USC star JuJu Watkins reaches Caitlin Clark’s far-reaching fame, but you can see it building.

New poll numbers indicate that Chicago Mayor Brandon Johnson has a lower approval rating than any sitting politician in the ...

President Donald Trump agreed to delay 25% tariffs on Canada and Mexico for a month after both US neighbors agreed to take ...

The 10-year yield declined 0.024 percentage point to 4.542% today. The price rose 6/32 to 97 23/32. --Yield is off 0.260 percentage point from its 52-week high of 4.802% hit Monday, Jan. 13, 2025 ...

While FPIs sold over $9 Billion in January 2025, the growth-oriented Union Budget can just change the narrative ...

At the end of December 2024, the firm had AUD 5.1 billion in net debt, gearing elevated at 165%. We now don't expect gearing to be back to a more palatable 30% before fiscal 2030, unless an equity ...

Former England boss Stuart Lancaster has been sacked from his job as Racing 92 head coach. The 55-year-old joined Racing in ...

Tuscaloosa Police were called to Sharpe's Landing on Lake Tuscaloosa. A body was found there near the boat landing about ...

Shell plc (NYSE:SHEL) shares are trading higher following fourth-quarter results. Revenue of $66.28 billion missed the ...